# Shenzhen MileBot Robotics Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shenzhen-milebot-robotics-co

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.milebot.com.cn
- Latest round: Series A (Aug 26, 2020)
- Investors on record: 2

## About

Based in Shenzhen, China and established in 2016, Shenzhen MileBot Robotics Co.,Ltd., trading as Mile Bot, operates as a medical rehabilitation robot technology company that provides. The company has become the top 50 most valuable investment enterprises in China in October 2017. The robots of the company on display at China international medical equipment expo April 2018. The company cooperates with many companies such as Waseda University, Share Capital and Lenovo.
In August 2026, Shenzhen MileBot Robotics Co.,Ltd. raised a venture funding from China Capital Management.
The company provides medical rehabilitation robot for patients with stroke, spinal cord injury and parkinson's. The company adopts internet of things, big data and robot interaction technology. The company's products include lower limb rehabilitation exoskeleton robot BEAR-H1, treadmill robot moonwalker and transcranial magnetic stimulation (TMS) navigation robot. The business of the company includes preoperative planning, intraoperative diagnosis and treatment, and postoperative evaluation.
The company's revenue is generated by providing medical rehabilitation robotics technology.
Shenzhen MileBot Robotics Co.,Ltd. aims to advance intelligent rehabilitation and elderly-care solutions by expanding its AI-powered exoskeleton robotics portfolio, strengthening remote rehabilitation ecosystems, and accelerating the global commercialization of smart healthcare technologies.

## Funding rounds

- Series A, Aug 26, 2020 — Lenovo Capital and Incubator Group
- Angel, Apr 15, 2017 — Lenovo Capital and Incubator Group, Taiyou Fund

## Investors

- Lenovo Capital and Incubator Group (https://capitalatlas.ai/funds/lenovo-capital-and-incubator-group) — Angel, Series A
- Taiyou Fund — Angel